M.X. Welliver
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
- Radiation top 10%
- Advanced Radiotherapy Techniques
Papers in
-
- Sarcoma Diagnosis and Treatment 7
- Lung Cancer Diagnosis and Treatment 5
- Radiation Therapy and Dosimetry 3
- Oncology 13
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Min Pan (1 shared paper)Michael A. Reid (1 shared paper)Mei Kong (1 shared paper)Allison Quick (1 shared paper)Arnab Chakravarti (1 shared paper)Yi Rong (2 shared papers)Wenrui Duan (2 shared papers)Charles L. Hitchcock (2 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (9 papers)Journal of Clinical Oncology (5 papers)Journal of Thoracic Oncology (2 papers)PLoS ONE (2 papers)Blood (2 papers)
- Partner nations
- United StatesIsraelJapan
In The Last Decade
M.X. Welliver
24 papers receiving 349 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 113
- Radiation 57
- Oncology 109
- Pulmonary and Respiratory Medicine 88
- Molecular Biology 154
Countries citing papers authored by M.X. Welliver
This map shows the geographic impact of M.X. Welliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.X. Welliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.X. Welliver more than expected).
Fields of papers citing papers by M.X. Welliver
This network shows the impact of papers produced by M.X. Welliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.X. Welliver. The network helps show where M.X. Welliver may publish in the future.
Co-authors
The 25 scholars most cited alongside M.X. Welliver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 129 | |
| 2 | 2014 | 48 | |
| 3 | 2013 | 41 | |
| 4 | 2015 | 24 | |
| 5 | 2022 | 23 | |
| 6 | 2019 | 18 | |
| 7 | 2023 | 15 | |
| 8 | 2022 | 12 | |
| 9 | 2019 | 7 | |
| 10 | 2024 | 6 | |
| 11 | 2014 | 6 | |
| 12 | 2018 | 5 | |
| 13 | 2022 | 4 | |
| 14 | 2015 | 4 | |
| 15 | 2015 | 3 | |
| 16 | 2021 | 2 | |
| 17 | 2021 | 2 | |
| 18 | 2017 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2015 | 1 |
About M.X. Welliver
M.X. Welliver is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Radiation, having authored 29 papers that have together received 358 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (7 papers), Lung Cancer Diagnosis and Treatment (5 papers), Advanced Radiotherapy Techniques (5 papers), Soft tissue tumor case studies (3 papers), Medical Imaging Techniques and Applications (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Radiation Therapy and Dosimetry (3 papers). The work is most often cited by research in Cancer Research (113 citations), Radiation (57 citations), Oncology (109 citations), Pulmonary and Respiratory Medicine (88 citations) and Molecular Biology (154 citations). M.X. Welliver has collaborated with scholars based in United States, Israel and Japan. Frequent co-authors include Min Pan, Michael A. Reid, Mei Kong, Allison Quick, Arnab Chakravarti, Yi Rong, Wenrui Duan, Charles L. Hitchcock, Gregory A. Otterson and Robert A. Baiocchi. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Journal of Thoracic Oncology, PLoS ONE and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.